AU2012298824B2 - Peptide nanoparticles and uses thereof - Google Patents

Peptide nanoparticles and uses thereof Download PDF

Info

Publication number
AU2012298824B2
AU2012298824B2 AU2012298824A AU2012298824A AU2012298824B2 AU 2012298824 B2 AU2012298824 B2 AU 2012298824B2 AU 2012298824 A AU2012298824 A AU 2012298824A AU 2012298824 A AU2012298824 A AU 2012298824A AU 2012298824 B2 AU2012298824 B2 AU 2012298824B2
Authority
AU
Australia
Prior art keywords
peptide
trp
leu
particle
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2012298824A
Other languages
English (en)
Other versions
AU2012298824A1 (en
Inventor
Gaudenz Danuser
Christian Dittrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of AU2012298824A1 publication Critical patent/AU2012298824A1/en
Application granted granted Critical
Publication of AU2012298824B2 publication Critical patent/AU2012298824B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2012298824A 2011-08-23 2012-08-23 Peptide nanoparticles and uses thereof Expired - Fee Related AU2012298824B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161526526P 2011-08-23 2011-08-23
US61/526,526 2011-08-23
PCT/US2012/052027 WO2013028843A1 (en) 2011-08-23 2012-08-23 Peptide nanoparticles and uses thereof

Publications (2)

Publication Number Publication Date
AU2012298824A1 AU2012298824A1 (en) 2014-03-20
AU2012298824B2 true AU2012298824B2 (en) 2017-06-01

Family

ID=46826904

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012298824A Expired - Fee Related AU2012298824B2 (en) 2011-08-23 2012-08-23 Peptide nanoparticles and uses thereof

Country Status (19)

Country Link
US (1) US8828928B2 (cg-RX-API-DMAC7.html)
EP (1) EP2748182B1 (cg-RX-API-DMAC7.html)
JP (1) JP2014524477A (cg-RX-API-DMAC7.html)
KR (1) KR20140068087A (cg-RX-API-DMAC7.html)
CN (1) CN104011065B (cg-RX-API-DMAC7.html)
AU (1) AU2012298824B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014004014A2 (cg-RX-API-DMAC7.html)
CA (1) CA2845886A1 (cg-RX-API-DMAC7.html)
CL (1) CL2014000418A1 (cg-RX-API-DMAC7.html)
DK (1) DK2748182T3 (cg-RX-API-DMAC7.html)
ES (1) ES2610779T3 (cg-RX-API-DMAC7.html)
HU (1) HUE031511T2 (cg-RX-API-DMAC7.html)
IL (1) IL231005A0 (cg-RX-API-DMAC7.html)
MX (1) MX2014002062A (cg-RX-API-DMAC7.html)
PT (1) PT2748182T (cg-RX-API-DMAC7.html)
RU (1) RU2014110901A (cg-RX-API-DMAC7.html)
SG (1) SG11201400073SA (cg-RX-API-DMAC7.html)
WO (1) WO2013028843A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201401210B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
WO2017139746A1 (en) * 2016-02-11 2017-08-17 Mark Daniels Posh inhibitor complex biomolecules and amphiphile micelles
CA3018561A1 (en) 2016-03-21 2017-09-28 Rhode Island Council On Postsecondary Education Ph-sensitive peptides
DE202017007363U1 (de) * 2016-12-16 2021-02-16 The Brigham And Women's Hospital, Inc. Zusammensetzung von Partikeln mit Eisenoxidkernen
CN106832003B (zh) * 2017-02-15 2021-01-05 中国药科大学 一种酸敏性多肽及其应用
EP3773483A4 (en) 2018-04-06 2022-01-26 Amma Therapeutics, Inc. Composition for controlled release of therapeutic agents
US12319711B2 (en) 2019-09-20 2025-06-03 Northwestern University Spherical nucleic acids with tailored and active protein coronae
US12378560B2 (en) 2019-10-29 2025-08-05 Northwestern University Sequence multiplicity within spherical nucleic acids
CN114516819B (zh) * 2022-02-25 2024-02-27 顺毅宜昌化工有限公司 一种n,n’-二乙酰基肼的制备方法
WO2023244536A2 (en) * 2022-06-13 2023-12-21 Neubase Therapeutics, Inc. Oligonucleotide analogue formulations
CN116004221B (zh) * 2022-12-15 2023-12-19 湖南卓润生物科技有限公司 环肽的新应用、吖啶标记复合物与制备方法、检测试剂盒

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270960A (en) 1964-09-11 1966-09-06 Sperry Rand Corp Fluid sensor
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3872925A (en) 1973-04-24 1975-03-25 Gearhart Owen Industries Through-tubing bridge plug
US3842067A (en) 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
JPS5726506B2 (cg-RX-API-DMAC7.html) 1974-03-08 1982-06-04
US4105603A (en) 1977-03-28 1978-08-08 The Salk Institute For Biological Studies Peptides which effect release of hormones
US4511390A (en) 1983-06-10 1985-04-16 E. I. Du Pont De Nemours And Company Aralkylcarbamoyl peptide alcohols
US5643873A (en) 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US5654276A (en) 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
FR2736642B1 (fr) 1995-07-10 1997-09-12 Pasteur Institut Immunovecteurs, notamment anticorps et fragments d'anticorps utilisables pour le transport intracellulaire et intranucleaire de principes biologiquement actifs notamment d'haptenes, de proteines et d'acides nucleiques
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
WO2001009191A1 (en) 1999-08-02 2001-02-08 Synt:Em S.A. Computational design methods for making molecular mimetics
CA2439400A1 (en) 2001-02-26 2002-09-06 The Regents Of The University Of California Non-oligomerizing tandem fluorescent proteins
CA2572964C (en) 2004-07-06 2018-03-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
JP6088123B2 (ja) * 2008-02-01 2017-03-01 アルファ−オー・ペプチドズ・アーゲーＡｌｐｈａ−Ｏ Ｐｅｐｔｉｄｅｓ Ａｇ ワクチンとして有用な自己会合ペプチドナノ粒子
US20110112040A1 (en) * 2008-04-28 2011-05-12 President And Fellows Of Harvard College Supercharged proteins for cell penetration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Dittrich, C. and Meier, W. 'Solid peptide nanoparticles - Structural characterization and quantification of cargo encapsulation' Macromolecular Bioscience, 2010, vol 10, page 1406-1415 *

Also Published As

Publication number Publication date
MX2014002062A (es) 2014-05-28
CN104011065B (zh) 2017-06-30
KR20140068087A (ko) 2014-06-05
US20130064895A1 (en) 2013-03-14
IL231005A0 (en) 2014-03-31
SG11201400073SA (en) 2014-03-28
CA2845886A1 (en) 2013-02-28
AU2012298824A1 (en) 2014-03-20
EP2748182A1 (en) 2014-07-02
RU2014110901A (ru) 2015-09-27
CL2014000418A1 (es) 2014-07-25
US8828928B2 (en) 2014-09-09
ES2610779T3 (es) 2017-05-03
NZ622045A (en) 2016-02-26
ZA201401210B (en) 2015-12-23
WO2013028843A1 (en) 2013-02-28
PT2748182T (pt) 2017-01-20
DK2748182T3 (en) 2017-02-06
JP2014524477A (ja) 2014-09-22
CN104011065A (zh) 2014-08-27
EP2748182B1 (en) 2016-10-19
BR112014004014A2 (pt) 2020-10-27
HUE031511T2 (en) 2017-07-28

Similar Documents

Publication Publication Date Title
AU2012298824B2 (en) Peptide nanoparticles and uses thereof
US20150218252A1 (en) Self-assembling peptides, peptide nanostructures and uses thereof
AU2017200766B2 (en) Liposome compositions and methods of use thereof
KR101475447B1 (ko) 자기-조립 블록 코폴리머의 베시클 그리고 그것의 제조 및 사용 방법
WO2021167107A1 (ja) ヒトトランスフェリンレセプター結合ペプチド
US20100098748A1 (en) Arg-Gly-Asp (RGD) Sequence Containing Cyclic Peptide and Its Active Targeting Liposomes
WO2010099510A2 (en) Amino acid-based compounds, their methods of use, and methods of screening
CA2668638A1 (en) Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
US20240336655A1 (en) Amphiphilic peptides for nucleic acid and protein delivery
HK1193115B (en) Peptide nanoparticles and uses thereof
HK1193115A (en) Peptide nanoparticles and uses thereof
NZ622045B2 (en) Peptide nanoparticles and uses thereof
NL2016207B1 (en) Selective cell penetrating peptides.
Dittrich et al. Solid peptide nanoparticles–Structural characterization and quantification of cargo encapsulation
JP7068711B2 (ja) 細胞質送達ペプチド
JP7610308B2 (ja) ペプチド及び該ペプチドを含む会合体又は組成物
TWI362270B (cg-RX-API-DMAC7.html)
Navarro Barreda Macro-and nanoscale self-assembled amino acid derivatives as reduction-sensitive and photoactive materials
CN115232195A (zh) 寡肽二维纳米材料及其应用
HK40090445A (zh) 靶组织特异性递送型药物递送系统用胶囊的用途
WO2020207974A1 (en) Cell-penetrating conjugate systems
Ruenraroengsak Studies of diffusion in cells using a self-fluorescent dendrimer
JP2021038184A (ja) 難水溶性薬物の複合体及びその製造方法

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application